Cargando…

Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway

ETHNOPHARMACOLOGICAL RELEVANCE: Acute lung injury (ALI) is a common manifestation of COVID-19. Xuanfei Baidu Formula(XFBD) is used in China to treat mild or common damp-toxin obstructive pulmonary syndrome in COVID-19 patients. However, the active ingredients of XFBD have not been extensively studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yanru, Luo, Lifei, Zhang, Meng, Song, Xinbo, Wang, Ping, Zhang, Han, Zhang, Jingze, Liu, Dailin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562620/ https://www.ncbi.nlm.nih.gov/pubmed/36252879 http://dx.doi.org/10.1016/j.jep.2022.115833

Ejemplares similares

Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
por: Li, Zhenhao, et al.
Publicado: (2023)

Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats
por: He, Qiaoyu, et al.
Publicado: (2022)

Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2021)

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2022)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 M(pro)
por: Zhang, Min, et al.
Publicado: (2023)

Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms
por: Meng, Tiantian, et al.
Publicado: (2023)

The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Li, Fan, et al.
Publicado: (2021)

Xuanfei Baidu Decoction regulates NETs formation via CXCL2/CXCR2 signaling pathway that is involved in acute lung injury
por: Zhou, Mengen, et al.
Publicado: (2023)

Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway
por: Li, Caixia, et al.
Publicado: (2023)

Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics
por: Xiong, Li, et al.
Publicado: (2022)

Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
por: Wang, Yuying, et al.
Publicado: (2022)

Efficacy and safety of Xuanfei Baidu granules for treating COVID-19: A protocol for systematic review and meta-analysis
por: Zhao, Jisen, et al.
Publicado: (2021)

Screening out anti-inflammatory or anti-viral targets in Xuanfei Baidu Tang through a new technique of reverse finding target
por: Wang, Zixuan, et al.
Publicado: (2021)

Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
por: Wang, Yuying, et al.
Publicado: (2022)

Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy
por: Li, Yujia, et al.
Publicado: (2021)

Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial
por: Xiong, Wu-zhong, et al.
Publicado: (2020)

Immune function of Chinese formula Qingwen Baidu granule in broilers
por: Guo, Shijin, et al.
Publicado: (2015)

Bioactive Components from Qingwen Baidu Decoction against LPS-Induced Acute Lung Injury in Rats
por: Zhang, Qi, et al.
Publicado: (2017)

Renshen Baidu Powder Attenuated Intestinal Inflammation and Apoptosis in Ulcerative Colitis Rats through the Inhibition of PI3K/AKT/NF-κB Signaling Pathway
por: Zhang, Peixu, et al.
Publicado: (2022)

Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation
por: Zhang, Bo, et al.
Publicado: (2017)

Metformin attenuates LPS-induced neuronal injury and cognitive impairments by blocking NF-κB pathway
por: Zhou, Chenliang, et al.
Publicado: (2021)

(+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK/NFκB signaling
por: Wang, Huanhuan, et al.
Publicado: (2018)

Alprostadil attenuates LPS-induced cardiomyocyte injury by inhibiting the Wnt5a/JNK/NF-κB pathway
por: Yu, T., et al.
Publicado: (2019)

PARP-1 Inhibitor, DPQ, Attenuates LPS-Induced Acute Lung Injury through Inhibiting NF-κB-Mediated Inflammatory Response
por: Wang, Gang, et al.
Publicado: (2013)

The Role of Autophagy in Kidney Inflammatory Injury via the NF-κB Route Induced by LPS
por: Wu, Yu, et al.
Publicado: (2015)

Xuanfei Pingchuan Capsules Ameliorate Autophagy in Human Bronchial Epithelial Cells by Inhibiting p38 Phosphorylation
por: Xue, Xiaoming, et al.
Publicado: (2021)

Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB
por: Zhu, Tao, et al.
Publicado: (2013)

NF-κB inhibition attenuates LPS-induced TLR4 activation in monocyte cells
por: Wan, Jian, et al.
Publicado: (2016)

Anti-Inflammatory Pyranochalcone Derivative Attenuates LPS-Induced Acute Kidney Injury via Inhibiting TLR4/NF-κB Pathway
por: Shi, Min, et al.
Publicado: (2017)

Renshen Baidu powder protects ulcerative colitis via inhibiting the PI3K/Akt/NF-κB signaling pathway
por: Ye, Zhen, et al.
Publicado: (2022)

Inosine Pretreatment Attenuates LPS-Induced Lung Injury through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo
por: Mao, Bingyong, et al.
Publicado: (2022)

Emodin Ameliorates LPS-Induced Acute Lung Injury, Involving the Inactivation of NF-κB in Mice
por: Xiao, Min, et al.
Publicado: (2014)

HMBOX1 attenuates LPS-induced periodontal ligament stem cell injury by inhibiting CXCL10 expression through the NF-κB signaling pathway
por: Nie, Minyuan, et al.
Publicado: (2022)

Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
por: WEI, Wen-Long, et al.
Publicado: (2021)

Nicorandil Attenuates LPS-Induced Acute Lung Injury by Pulmonary Endothelial Cell Protection via NF-κB and MAPK Pathways
por: He, Mengyu, et al.
Publicado: (2019)

Geraniin attenuates LPS-induced acute lung injury via inhibiting NF-κB and activating Nrf2 signaling pathways
por: Zhu, Guangfa, et al.
Publicado: (2017)

Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway
por: Deng, Guiming, et al.
Publicado: (2017)

Anti-Inflammatory Effects of Camellia fascicularis Polyphenols via Attenuation of NF-κB and MAPK Pathways in LPS-Induced THP-1 Macrophages
por: Gao, Miaozi, et al.
Publicado: (2022)

Bergamottin alleviates LPS-induced acute lung injury by inducing SIRT1 and suppressing NF-κB
por: An, Ning, et al.
Publicado: (2021)

Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis
por: Wang, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ghgsco8dfkgbt7kb5cfib8sqq